Home/Filings/4/0001104659-26-001291
4//SEC Filing

Kaiser Peter 4

Accession 0001104659-26-001291

CIK 0001393434other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:05 PM ET

Size

8.0 KB

Accession

0001104659-26-001291

Insider Transaction Report

Form 4
Period: 2026-01-02
Kaiser Peter
Chief Development Officer
Transactions
  • Award

    Common Stock

    2026-01-02+79,112271,918 total
  • Award

    Stock Option (Right to Buy)

    2026-01-02+240,932240,932 total
    Exercise: $11.82Exp: 2036-01-01Common Stock (240,932 underlying)
Footnotes (3)
  • [F1]On January 2, 2026, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
  • [F2]Includes 1,373 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on December 31, 2025.
  • [F3]Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Issuer

OCULAR THERAPEUTIX, INC

CIK 0001393434

Entity typeother

Related Parties

1
  • filerCIK 0002011869

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:05 PM ET
Size
8.0 KB